Stocks-INO-Inovio Pharmaceuticals Inc

INO Inovio Pharmaceuticals Inc

1.68 0.02 (1.20%)
Delayed Prices By NASDAQ, in USD Market Closed
Invest
Invest

Overview

Prev Close1.68
Day's Range 1.62 - 1.68
52 Week Range 1.37 - 4.27
Average Volume (3M)5.57M
1-Year Return-59.57%
Beta0.5114
Market Cap419.14M
P/E Ratio
Revenue10.98M
EPS-1.4738
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.715/08/202226/10/202209/01/20231.501.752.002.252.502.753.00
Chart times in UTC
Industry Pharmaceuticals Major
CEO Jacqueline E. Shea, PhD
Employees 317

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: Inovio Pharmaceuticals Inc's revenues decreased by 76.05% and amounted to 1.77M. Net income decreased by 81.58% to -304.09M. Net assets decreased by 13.34% to 399.67M and EPS decreased from -1.07 to -1.45.
INO's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
N/A
Net Profit Margin
-5,644.03%
Operating Margin
-2,889.17%
Return On Investment
-83.48%
12/21
03/22
06/22
09/22
Total Revenue
839.12K
199.07K
784.4K
9.15M
Gross Profit
N/A
N/A
-625.66K
7.79M
Operating Income
-105.51M
-71.73M
-104.14M
-35.76M
Net Income
-107.38M
-79.07M
-108.5M
-37.78M